Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology-Reference-Cited by-同舟云学术

Intravenous immunoglobulins for treatment of connective tissue diseases in dermatology

Published:2017-09-01 Issue:9-10 Volume:168 Page:213-217
ISSN:0043-5341
Container-title:Wiener Medizinische Wochenschrift
language:en
Short-container-title:Wien Med Wochenschr

Author:

Dourmishev Lyubomir A.,Guleva Dimitrina V.,Miteva Ljubka G.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/article/10.1007/s10354-017-0595-x/fulltext.html

Reference57 articles.

1. Bruton OC. Agammaglobulinemia. Pediatrics. 1952;16:722–8.

2. Imbach P, Barandun S, d’Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981;1:1228–31.

3. Cherin P, Cabane J. Relevant criteria for selecting an intravenous immunoglobulin preparation for clinical use. BioDrugs. 2010;24:211–23.

4. Baleva M, Nikolov K. The role of intravenous immunoglobulin preparations in the treatment of systemic sclerosis. Int J Rheumatol. 2011;2011:829751.

5. Nikolov K, Nikolova-Vlahova M, Baleva M. Side effects of intravenous immunoglobulins (IVIG). In: Allegro R, editor. Plasmopheresis and Immunoglobulins. New York: Nova; 2014. pp. 191–204.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-dose immunoglobulin therapy for steroid-resistant myositis in juvenile localized scleroderma;Pediatrics & Neonatology;2022-09

2. Autoimmune connective tissue diseases in the COVID-19 pandemic;Clinics in Dermatology;2021-01

3. Intravenous immunoglobulin treatment: Where do dermatologists stand?;Dermatologic Therapy;2019-03-04

4. Bulgarian rheumatology: science and practice in a cost-constrained environment;Rheumatology International;2018-11-09

5. Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review;Clinical Reviews in Allergy & Immunology;2017-10-31